September 2012

Volume 8 Supplement Q

Editorial

Welcome to PCR London Valves 2012

Thomas M, Windecker S

September 30, 2012 | 10.4244/EIJV8SQA1

PCR London Valves: a global course on valvular heart disease under the auspices of PCR and EAPCI

Fajadet J

September 30, 2012 | 10.4244/EIJV8SQA2

Building on the shoulders of giants: the Valve Academic Research Consortium (VARC) initiative towards a global framework to guide valvular heart disease trials

Serruys P

September 30, 2012 | 10.4244/EIJV8SQA3

Historical perspective – 10th year anniversary of TAVI

Historical perspective: 10th year anniversary of TAVI

Cribier A

September 30, 2012 | 10.4244/EIJV8SQA4

Topic review – TAVI and aortic regurgitation

Mechanisms and prediction of aortic regurgitation after TAVI

Petronio AS, Giannini C, De Carlo M

September 30, 2012 | 10.4244/EIJV8SQA5

Imaging and quantification of aortic regurgitation after TAVI

Ewe S, Delgado V, Bax J

September 30, 2012 | 10.4244/EIJV8SQA6

Prognostic impact of aortic regurgitation after transcatheter aortic valve implantation

Jilaihawi H, Makkar R

September 30, 2012 | 10.4244/EIJV8SQA7

Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation

Hayashida K, Lefèvre T

September 30, 2012 | 10.4244/EIJV8SQA8

Review articles

Paravalvular leaks: mechanisms, diagnosis and management

Garcia E, Sandoval J, Unzue L, Hernández-Antolín R, Almería C, Macaya C

September 30, 2012 | 10.4244/EIJV8SQA9

Transcatheter mitral valve interventions: current status and future perspective

Feldman T, Ali O

September 30, 2012 | 10.4244/EIJV8SQA10

Transcatheter aortic valve implantation and cerebrovascular accidents

Stortecky S, Wenaweser P, Windecker S

September 30, 2012 | 10.4244/EIJV8SQA11

Innovations / Novel technologies

Boston Scientific Lotus valve

Meredith I, Hood K, Haratani N, Allocco DJ, Dawkins K

September 30, 2012 | 10.4244/EIJV8SQA12

Direct Flow Medical valve

Bijuklic K, Tübler T, Low R, Grube E, Schofer J

September 30, 2012 | 10.4244/EIJV8SQA13

Edwards CENTERA valve

Ribeiro HB, Urena M, Kuck K, Webb JG, Rodés-Cabau J

September 30, 2012 | 10.4244/EIJV8SQA14

Edwards SAPIEN 3 valve

Binder R, Rodés-Cabau J, Wood DA, Webb JG

September 30, 2012 | 10.4244/EIJV8SQA15

JenaValve

Treede H, Rastan A, Ferrari M, Ensminger S, Figulla HR, Mohr F

September 30, 2012 | 10.4244/EIJV8SQA16

Medtronic CoreValve Evolut valve

Sinning J, Werner N, Nickenig G, Grube E

September 30, 2012 | 10.4244/EIJV8SQA17

St Jude Medical Portico valve

Manoharan G, Spence M, Rodés-Cabau J, Webb JG

September 30, 2012 | 10.4244/EIJV8SQA18

Symetis ACURATE TA valve

Kempfert J, Möllmann H, Walther T

September 30, 2012 | 10.4244/EIJV8SQA19

PCR London Valves 2012 abstracts

Transcatheter aortic valve replacement for severe aortic stenosis in elderly patients with severely depressed left ventricular function

September 30, 2012

Prognostic implications of moderate and severe mitral regurgitation in contemporary clinical care

September 30, 2012

Thirty-day outcomes after TAVI in patients with severe aortic stenosis and moderate or severe mitral regurgitation

September 30, 2012

Real-world European experience with the transcatheter treatment of significant mitral regurgitation: demographics and procedural outcomes

September 30, 2012

Transcatheter aortic valve implantation for pure severe native aortic regurgitation

September 30, 2012

Predictors of post-procedure paraprosthetic aortic regurgitation following self-expanding valve implantation: a multicentre registry analysis

September 30, 2012

Impact of post-procedural aortic regurgitation on mortality after TAVI

September 30, 2012

Percutaneous closure of paravalvular aortic leaks with the Amplatzer Vascular Plug III ®, late clinical follow-up

September 30, 2012

Effects of preoperative tricuspid regurgitation on mitral regurgitation treatment with the MitraClip device in high-risk patients

September 30, 2012

MitraClip repair for severe mitral regurgitation: initial Asian experience

September 30, 2012

Percutaneous closure of paravalvular mitral prosthetic regurgitation with the Amplatzer Vascular Plug III®

September 30, 2012

Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry

September 30, 2012

Impact of experience on TAVI outcome: a propensity-matched analysis from the pragmatic plus initiative

September 30, 2012

Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?

September 30, 2012

Comparison of new EuroSCORE II with logistic EuroSCORE and STS score in predicting 30-day and one-year mortality in patients undergoing TAVI

September 30, 2012

Comparison of EuroSCORE and EuroSCORE II in predicting short-term mortality in patients undergoing TAVI

September 30, 2012

Comparison of effectiveness and safety of TAVI in patients ≥90 years of age versus <90 years of age

September 30, 2012

Transcatheter mitral valve-in-valve/valve-in-ring implantations for degenerative post-surgical valves: results from the global valve-in-valve registry

September 30, 2012

The Swedish TAVI registry: all 566 procedures in 2008-2011

September 30, 2012

The Ibero-American Transcatheter Aortic Valve Implantation Registry: acute and long-term results

September 30, 2012

Initial experience with transfemoral implantation of the prosthesis Edwards SAPIEN XT without previous valvuloplasty in patients with severe aortic stenosis

September 30, 2012

Transcatheter valve-in-valve implantation in degenerated aortic bioprostheses via transfemoral access with the Edwards SAPIEN XT transcatheter heart valve

September 30, 2012

TAVI for patients with severe bicuspid aortic valve stenosis

September 30, 2012

Percutaneous transfemoral transcatheter aortic valve implantation (pTAVI): a single-centre experience comparing general with local anaesthesia

September 30, 2012

The European experience with the direct-aortic approach for a self-expandable transcatheter aortic bioprosthesis implantation

September 30, 2012

Transseptal antegrade transcatheter aortic valve replacement for no-access option patients. A contemporary experience

September 30, 2012

Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes

September 30, 2012

Is the percutaneous femoral approach for TAVI always better? A comparison with a femoral surgical cut-down

September 30, 2012

One single centre’s short- and long-term outcomes after TAVI: no differences between the transfemoral and transapical approach

September 30, 2012

Balloon-expandable sheath for borderline vascular access in transfemoral TAVI

September 30, 2012

Predictive factors of successful repeat percutaneous mitral commissurotomy for mitral restenosis after previous percutaneous commissurotomy

September 30, 2012

Concept of the central clip: when to use one or two Mitraclips®

September 30, 2012

Incidence of permanent pacemaker implantation after TAVI and re-evaluation of the indications after the periprocedural period

September 30, 2012

Achieving a low pacing rate with CoreValve TAVI: high implantation, new delivery catheter, or both?

September 30, 2012

How does inflammation influence left ventricular function after TAVI?

September 30, 2012

Early and late changes in quality of life following TAVI using the transfemoral and transapical approaches

September 30, 2012

Emergency and prophylactic use of miniaturised veno-arterial extracorporeal membrane oxygenation (vaECMO) in transcatheter aortic valve implantation (TAVI)

September 30, 2012